Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Second phase II trial for GVAX pancreatic cancer vaccine

May 31, 2002

Clinical data on one of Igeneon's cancer vaccine candidates discussed at ASCO meeting

May 31, 2002

Oncophage granted orphan drug status in renal cell carcinoma

May 30, 2002

IND filed for MDX-060

May 30, 2002

Intralesional CpG ODN evaluated in patients with basal cell carcinoma and melanoma

May 28, 2002

Sosei licenses KS Biomedix's TransMID product for recurrent high-grade glioma in Japan

May 28, 2002

Phase I EMD-72000 results presented at ASCO

May 28, 2002

Pharmexa prepares to file IND for AutoVac HER-2 Protein pharmaccine for breast cancer

May 27, 2002

Biomira updates progress of Theratope and BLP25

May 27, 2002

Antisense oligonucleotide targeting TGF-beta2 shows promise for malignant glioma, other solid tumors

May 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...